UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 13, 2020
Accession Number:
0001104659-20-019152
Submission Type:
POS AM
CIK:
0001138776
Company Name:
Aevi Genomic Medicine, LLC
File Number:
333-182740